Paper41545904
Particulate matter 2.5 promotes bladder cancer cell migration and invasion through the crosstalk between integrin-mediated MAPK/ERK and Wnt/β-catenin pathways.
Cheng YT and 5 others. Part Fibre Toxicol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Particulate matter 2.5 promotes bladder cancer cell migration and invasion through the crosstalk between integrin-mediated MAPK/ERK and Wnt/β-catenin pathways. Papers, record 41545904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545904
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Particulate matter 2.5 promotes bladder cancer cell migration and invasion through the crosstalk between integrin-mediated MAPK/ERK and Wnt/β-catenin pathways.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Movement | Major topic |
| Particulate Matter | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Wnt Signaling Pathway | Major topic |
| MAP Kinase Signaling System | Major topic |
| Air Pollutants | Major topic |
| Humans | |
| Neoplasm Invasiveness | |
| Cell Line, Tumor | |
| beta Catenin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 111-2320-B-002-020-MY3 | National Science and Technology Council | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21368895 | Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis. | Cell Death Dis | 2011 | https://conductscience.org/library/papers/21368895 | PubMed |
| 2 | 33140906 | Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer. | Chembiochem | 2021 | https://conductscience.org/library/papers/33140906 | PubMed |
| 3 | 33340660 | Wnt signalling pathway in bladder cancer. | Cell Signal | 2021 | https://conductscience.org/library/papers/33340660 | PubMed |
| 4 | 22593577 | Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22593577 | PubMed |
| 5 | 29872723 | Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway. | NPJ Precis Oncol | 2018 | https://conductscience.org/library/papers/29872723 | PubMed |
| 6 | 29247021 | First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study. | Cancer Discov | 2018 | https://conductscience.org/library/papers/29247021 | PubMed |
| 7 | 28656580 | Potential lung carcinogenicity induced by chronic exposure to PM2.5 in the rat. | Environ Sci Pollut Res Int | 2017 | https://conductscience.org/library/papers/28656580 | PubMed |
| 8 | 11205306 | Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer. | Anticancer Res | 2000 | https://conductscience.org/library/papers/11205306 | PubMed |
| 9 | 32037398 | Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32037398 | PubMed |
| 10 | 31133044 | Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31133044 | PubMed |
| 11 | 29630366 | Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε. | J Med Chem | 2018 | https://conductscience.org/library/papers/29630366 | PubMed |
| 12 | 37245545 | Integrins in cancer: Emerging mechanisms and therapeutic opportunities. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37245545 | PubMed |
| 13 | 34337511 | The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan. | Eur Urol Open Sci | 2021 | https://conductscience.org/library/papers/34337511 | PubMed |
| 14 | 39090580 | The safety and efficacy of binimetinib for lung cancer: a systematic review. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/39090580 | PubMed |
| 15 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 16 | 32156780 | Blockade of β-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. | Cancer Res | 2020 | https://conductscience.org/library/papers/32156780 | PubMed |
| 17 | 30431139 | Exosomes derived from PM2.5‑treated lung cancer cells promote the growth of lung cancer via the Wnt3a/β‑catenin pathway. | Oncol Rep | 2019 | https://conductscience.org/library/papers/30431139 | PubMed |
| 18 | 19424573 | Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells. | Int J Oncol | 2009 | https://conductscience.org/library/papers/19424573 | PubMed |
| 19 | 37770930 | Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37770930 | PubMed |
| 20 | 30032142 | MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/β-Catenin Signaling. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30032142 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42279296 | Naringenin, a Food-Derived Flavanone, Suppresses ITGA11-Associated Gastric Cancer Progression via the FAK/PI3K/AKT/mTOR Axis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279296 |
Source PubMed
Genes42
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545904
GET https://conductscience.org/api/papers/v1/41545904/references?page=2